XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,496,000 | +88627.3% | 600,000 | 0.0% | 1.09% | +1.9% |
| Q2 2023 | $23,100 | +7.6% | 600,000 | 0.0% | 1.07% | +1.5% |
| Q1 2023 | $21,474 | -99.9% | 600,000 | 0.0% | 1.06% | -15.4% |
| Q4 2022 | $23,658,000 | +9.2% | 600,000 | 0.0% | 1.25% | +2.4% |
| Q3 2022 | $21,660,000 | +18.7% | 600,000 | 0.0% | 1.22% | +5.4% |
| Q2 2022 | $18,252,000 | -0.5% | 600,000 | 0.0% | 1.16% | +22.6% |
| Q1 2022 | $18,342,000 | -2.1% | 600,000 | 0.0% | 0.94% | +29.5% |
| Q4 2021 | $18,744,000 | +43.1% | 600,000 | -30.0% | 0.73% | +59.3% |
| Q3 2021 | $13,095,000 | -17.9% | 857,000 | 0.0% | 0.46% | -18.8% |
| Q2 2021 | $15,957,000 | +140.2% | 857,000 | +42.8% | 0.56% | +144.8% |
| Q3 2020 | $6,642,000 | -11.7% | 600,000 | 0.0% | 0.23% | -30.5% |
| Q2 2020 | $7,524,000 | +10.6% | 600,000 | 0.0% | 0.33% | -28.7% |
| Q1 2020 | $6,804,000 | +71.8% | 600,000 | +100.0% | 0.46% | +5.7% |
| Q3 2018 | $3,960,000 | – | 300,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |